Table of Contents Communicable Diseases Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Communicable Diseases Therapeutics 1.1 Communicable Diseases Therapeutics Market Overview 1.1.1 Communicable Diseases Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Communicable Diseases Therapeutics Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Communicable Diseases Therapeutics Market by Type 1.3.1 Global Communicable Diseases Therapeutics Revenue (Million US$) and Growth Comparison by Type (2014-2025) 1.3.2 Global Communicable Diseases Therapeutics Revenue Market Share by Type in 2018 1.3.3 HIV 1.3.4 Influenza 1.3.5 TB 1.3.6 Malaria 1.3.7 Hepatitis 1.3.8 HPV 1.4 Communicable Diseases Therapeutics Market by End Users/Application 1.4.1 Hospital 1.4.2 Clinic 1.4.3 Other 2 Global Communicable Diseases Therapeutics Competition Analysis by Players 2.1 Global Communicable Diseases Therapeutics Market Size (Million US$) by Players (2014-2019) 2.2 Competitive Status 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 Mergers & Acquisitions, Expansion Plans 3 Company (Top Players) Profiles and Key Data 3.1 Novartis 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Communicable Diseases Therapeutics Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Gilead 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Communicable Diseases Therapeutics Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 GSK 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Communicable Diseases Therapeutics Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Janssen Pharmaceutical 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Communicable Diseases Therapeutics Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Roche 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Communicable Diseases Therapeutics Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 BioCryst Pharmaceuticals 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Communicable Diseases Therapeutics Revenue (Value) (2014-2019) 3.6.5 Recent Developments 3.7 Merck 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Communicable Diseases Therapeutics Revenue (Value) (2014-2019) 3.7.5 Recent Developments 3.8 Boehringer Ingelheim 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Communicable Diseases Therapeutics Revenue (Value) (2014-2019) 3.8.5 Recent Developments 4 Global Communicable Diseases Therapeutics Market Size by Type and Application (2014-2019) 4.1 Global Communicable Diseases Therapeutics Market Size by Type (2014-2019) 4.2 Global Communicable Diseases Therapeutics Market Size by Application (2014-2019) 4.3 Potential Application of Communicable Diseases Therapeutics in Future 4.4 Top Consumer/End Users of Communicable Diseases Therapeutics 5 North America Communicable Diseases Therapeutics Development Status and Outlook 5.1 North America Communicable Diseases Therapeutics Market Size (2014-2019) 5.2 North America Communicable Diseases Therapeutics Market Size and Market Share by Players (2014-2019) 5.3 North America Communicable Diseases Therapeutics Market Size by Application (2014-2019) 6 Europe Communicable Diseases Therapeutics Development Status and Outlook 6.1 Europe Communicable Diseases Therapeutics Market Size (2014-2019) 6.2 Europe Communicable Diseases Therapeutics Market Size and Market Share by Players (2014-2019) 6.3 Europe Communicable Diseases Therapeutics Market Size by Application (2014-2019) 7 China Communicable Diseases Therapeutics Development Status and Outlook 7.1 China Communicable Diseases Therapeutics Market Size (2014-2019) 7.2 China Communicable Diseases Therapeutics Market Size and Market Share by Players (2014-2019) 7.3 China Communicable Diseases Therapeutics Market Size by Application (2014-2019) 8 Rest of Asia Pacific Communicable Diseases Therapeutics Development Status and Outlook 8.1 Rest of Asia Pacific Communicable Diseases Therapeutics Market Size (2014-2019) 8.2 Rest of Asia Pacific Communicable Diseases Therapeutics Market Size and Market Share by Players (2014-2019) 8.3 Rest of Asia Pacific Communicable Diseases Therapeutics Market Size by Application (2014-2019) 9 Central & South America Communicable Diseases Therapeutics Development Status and Outlook 9.1 Central & South America Communicable Diseases Therapeutics Market Size (2014-2019) 9.2 Central & South America Communicable Diseases Therapeutics Market Size and Market Share by Players (2014-2019) 9.3 Central & South America Communicable Diseases Therapeutics Market Size by Application (2014-2019) 10 Middle East & Africa Communicable Diseases Therapeutics Development Status and Outlook 10.1 Middle East & Africa Communicable Diseases Therapeutics Market Size (2014-2019) 10.2 Middle East & Africa Communicable Diseases Therapeutics Market Size and Market Share by Players (2014-2019) 10.3 Middle East & Africa Communicable Diseases Therapeutics Market Size by Application (2014-2019) 11 Market Forecast by Regions and Application (2019-2025) 11.1 Global Communicable Diseases Therapeutics Market Size by Regions (2019-2025) 11.1.1 North America Communicable Diseases Therapeutics Revenue and Growth Rate (2019-2025) 11.1.2 Europe Communicable Diseases Therapeutics Revenue and Growth Rate (2019-2025) 11.1.3 China Communicable Diseases Therapeutics Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Communicable Diseases Therapeutics Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Communicable Diseases Therapeutics Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Communicable Diseases Therapeutics Revenue and Growth Rate (2019-2025) 11.2 Global Communicable Diseases Therapeutics Market Size by Application (2019-2025) 11.3 The Market Drivers in Future 12 Communicable Diseases Therapeutics Market Dynamics 12.1 Industry Trends 12.2 Market Drivers 12.3 Market Challenges 12.4 Porter’s Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Communicable Diseases Therapeutics Market Size (Million USD) Status and Outlook (2014-2025) Table Global Communicable Diseases Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2025) Figure Global Communicable Diseases Therapeutics Market Share by Regions (2014-2019) Figure North America Communicable Diseases Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Europe Communicable Diseases Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure China Communicable Diseases Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Rest of Asia Pacific Communicable Diseases Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Central & South America Communicable Diseases Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Middle East & Africa Communicable Diseases Therapeutics Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Communicable Diseases Therapeutics Market Share by Type in 2018 & 2025 Figure HIV Market Size (Million USD) and Growth Rate (2014-2019) Figure Influenza Market Size (Million USD) and Growth Rate (2014-2019) Figure TB Market Size (Million USD) and Growth Rate (2014-2019) Figure Malaria Market Size (Million USD) and Growth Rate (2014-2019) Figure Hepatitis Market Size (Million USD) and Growth Rate (2014-2019) Figure HPV Market Size (Million USD) and Growth Rate (2014-2019) Table Global Communicable Diseases Therapeutics Market Size (Million US$) Comparison by Application (2014-2025) Figure Global Communicable Diseases Therapeutics Market Share by Application in 2018 & 2025 Figure Communicable Diseases Therapeutics Market Size (Million USD) and Growth Rate in Hospital (2014-2019) Figure Communicable Diseases Therapeutics Market Size (Million USD) and Growth Rate in Clinic (2014-2019) Figure Communicable Diseases Therapeutics Market Size (Million USD) and Growth Rate in Other (2014-2019) Table Global Communicable Diseases Therapeutics Revenue (Million US$) by Players (2014-2019) Table Global Communicable Diseases Therapeutics Revenue Market Share by Players (2014-2019) Eigure Communicable Diseases Therapeutics Market Size Share by Players in 2018 Table Global Communicable Diseases Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Global Top 5 Players Communicable Diseases Therapeutics Market Share in 2018 Figure Global Top 10 Players Communicable Diseases Therapeutics Market Share in 2018 Table Communicable Diseases Therapeutics Key Players Product/Service Table Mergers & Acquisitions, Expansion Plans Table Novartis Basic Information List Table Novartis Description and Business Overview Table Novartis Communicable Diseases Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Communicable Diseases Therapeutics Business of Novartis (2014-2019) Table Novartis Communicable Diseases Therapeutics Recent Developments Table Gilead Basic Information List Table Gilead Description and Business Overview Table Gilead Communicable Diseases Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Communicable Diseases Therapeutics Business of Gilead (2014-2019) Table Gilead Communicable Diseases Therapeutics Recent Developments Table GSK Basic Information List Table GSK Description and Business Overview Table GSK Communicable Diseases Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Communicable Diseases Therapeutics Business of GSK (2014-2019) Table GSK Communicable Diseases Therapeutics Recent Developments Table Janssen Pharmaceutical Basic Information List Table Janssen Pharmaceutical Description and Business Overview Table Janssen Pharmaceutical Communicable Diseases Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Communicable Diseases Therapeutics Business of Janssen Pharmaceutical (2014-2019) Table Janssen Pharmaceutical Communicable Diseases Therapeutics Recent Developments Table Roche Basic Information List Table Roche Description and Business Overview Table Roche Communicable Diseases Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Communicable Diseases Therapeutics Business of Roche (2014-2019) Table Roche Communicable Diseases Therapeutics Recent Developments Table BioCryst Pharmaceuticals Basic Information List Table BioCryst Pharmaceuticals Description and Business Overview Table BioCryst Pharmaceuticals Communicable Diseases Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Communicable Diseases Therapeutics Business of BioCryst Pharmaceuticals (2014-2019) Table BioCryst Pharmaceuticals Communicable Diseases Therapeutics Recent Developments Table Merck Basic Information List Table Merck Description and Business Overview Table Merck Communicable Diseases Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Communicable Diseases Therapeutics Business of Merck (2014-2019) Table Merck Communicable Diseases Therapeutics Recent Developments Table Boehringer Ingelheim Basic Information List Table Boehringer Ingelheim Description and Business Overview Table Boehringer Ingelheim Communicable Diseases Therapeutics Products, Services and Solutions Table Revenue (Million US$) in Communicable Diseases Therapeutics Business of Boehringer Ingelheim (2014-2019) Table Boehringer Ingelheim Communicable Diseases Therapeutics Recent Developments Table Global Communicable Diseases Therapeutics Market Size by Type (2014-2019) (Million US$) Figure Global Communicable Diseases Therapeutics Revenue Market Share by Type in 2018 Table Global Communicable Diseases Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Global Communicable Diseases Therapeutics Revenue Market by Application in 2018 Table Top Consumer/End Users of Communicable Diseases Therapeutics Figure North America Communicable Diseases Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table North America Communicable Diseases Therapeutics Market Size by Players (2014-2019)(Million US$) Figure North America Communicable Diseases Therapeutics Market Size Share by Players in 2018 Table North America Communicable Diseases Therapeutics Market Size by Application (2014-2019) (Million US$) Figure North America Communicable Diseases Therapeutics Revenue Market Share by Application (2014-2019) Figure North America Communicable Diseases Therapeutics Market Size Share by Application in 2018 Figure Europe Communicable Diseases Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Europe Communicable Diseases Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Europe Communicable Diseases Therapeutics Market Size Share by Players in 2018 Table Europe Communicable Diseases Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Europe Communicable Diseases Therapeutics Revenue Market Share by Application (2014-2019) Figure Europe Communicable Diseases Therapeutics Market Size Share by Application in 2018 Figure China Communicable Diseases Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table China Communicable Diseases Therapeutics Market Size by Players (2014-2019)(Million US$) Figure China Communicable Diseases Therapeutics Market Size Share by Players in 2018 Table China Communicable Diseases Therapeutics Market Size by Application (2014-2019) (Million US$) Figure China Communicable Diseases Therapeutics Revenue Market Share by Application (2014-2019) Figure China Communicable Diseases Therapeutics Market Size Share by Application in 2018 Figure Rest of Asia Pacific Communicable Diseases Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Rest of Asia Pacific Communicable Diseases Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Rest of Asia Pacific Communicable Diseases Therapeutics Market Size Share by Players in 2018 Table Rest of Asia Pacific Communicable Diseases Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Rest of Asia Pacific Communicable Diseases Therapeutics Revenue Market Share by Application (2014-2019) Figure Rest of Asia Pacific Communicable Diseases Therapeutics Market Size Share by Application in 2018 Figure Central & South America Communicable Diseases Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Central & South America Communicable Diseases Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Central & South America Communicable Diseases Therapeutics Market Size Share by Players in 2018 Table Central & South America Communicable Diseases Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Central & South America Communicable Diseases Therapeutics Revenue Market Share by Application (2014-2019) Figure Central & South America Communicable Diseases Therapeutics Market Size Share by Application in 2018 Figure Middle East & Africa Communicable Diseases Therapeutics Market Size and Growth Rate(2014-2019) (Million USD) Table Middle East & Africa Communicable Diseases Therapeutics Market Size by Players (2014-2019)(Million US$) Figure Middle East & Africa Communicable Diseases Therapeutics Market Size Share by Players in 2018 Table Middle East & Africa Communicable Diseases Therapeutics Market Size by Application (2014-2019) (Million US$) Figure Middle East & Africa Communicable Diseases Therapeutics Revenue Market Share by Application (2014-2019) Figure Middle East & Africa Communicable Diseases Therapeutics Market Size Share by Application in 2018 Figure Global Communicable Diseases Therapeutics Market Size and Growth Rate (Value) (2019-2025) (Million US$) Table Global Communicable Diseases Therapeutics Market Size by Regions (2019-2025) (Million US$) Figure Global Communicable Diseases Therapeutics Market Size Share by Regions (2019-2025) Figure Global Communicable Diseases Therapeutics Market Size Share by Regions in 2025 Figure North America Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure China Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Communicable Diseases Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Table Global Communicable Diseases Therapeutics Market Size by Application (2019-2025) (Million USD) Figure Global Communicable Diseases Therapeutics Market Size by Application (2019-2025) Figure Global Communicable Diseases Therapeutics Market Size by Application in 2025 Table Global Communicable Diseases Therapeutics Market Size by Type (2019-2025) (Million US$) Figure Global Communicable Diseases Therapeutics Market Size by Type (2019-2025) Figure Global Communicable Diseases Therapeutics Market Size by Type in 2025 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure Porter's Five Forces Analysis Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Novartis Gilead GSK Janssen Pharmaceutical Roche BioCryst Pharmaceuticals Merck Boehringer Ingelheim